MedTrace Logo

Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)

NCT01620853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2015-02-06

No results posted yet for this study

Summary

The purpose of the study is the identification of chromosomal aberrations in non-small cell lung cancer (NSCLC) .

The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classifying ALK FISH stained lung samples.

Conditions

  • Non-small Cell Lung Cancer (NSCLC)

Sponsors & Collaborators

  • Applied Spectral Imaging Ltd.

    lead INDUSTRY

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01620853 on ClinicalTrials.gov